57 results
8-K
EX-10.01
ADAP
Adaptimmune Therapeutics Plc
26 Jan 22
Adaptimmune Announces Appointment of Cintia Piccina as Chief Commercial Officer
8:05am
or any Group Company into material disrepute; (v) any act or omission by Executive aiding or abetting a competitor, supplier or customer of the PLC … plans, customer lists, investors, and all papers, resumes and records (including computer records) of the documents containing such information
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
1 Aug 19
New Executive Team Announced at Adaptimmune
7:22am
, customer lists, investors, and all papers, resumes and records (including computer records) of the documents containing such information … or indirectly (through another person, entity or otherwise): (i) contact, solicit or accept the business of any customer, vendor or client of the Company
8-K
EX-10.1
ADAP
Adaptimmune Therapeutics Plc
27 Feb 24
Adaptimmune Hires Chief Commercial Officer in Advance of Q3 2024 PDUFA Date for Afami-cel, a Late-stage Product in the Company’s Sarcoma Franchise
8:13am
, supplier or customer of the PLC and/or any of its subsidiaries or affiliates to the material disadvantage or detriment of the PLC and/or any of its … and styles, product development plans, customer lists, investors, and all papers, resumes and records (including computer records) of the documents containing
10-K
2016 FY
EX-10.20
ADAP
Adaptimmune Therapeutics Plc
13 Mar 17
Annual report
12:00am
, trade secrets, data, formulae, product designs and styles, product development plans, customer lists, investors, and all papers, resumes and records … customer, vendor or client of the Company or affiliated company for any reason except for non-competing purposes unrelated to the use of T cell
10-K
EX-10.17
m7m62nz3ki4 11cht
13 Mar 17
Annual report
12:00am
8-K
EX-10.1
hm3tf 4qkm1
4 May 22
Adaptimmune Announces Appointment of Joanna Brewer as Chief Scientific Officer
8:20am
8-K
EX-10.1
0z0v m1yc0a10ppym
16 Dec 20
Departure of Directors or Certain Officers
5:01pm
10-K
EX-10.19
01dlk 954568v1vqj97
13 Mar 17
Annual report
12:00am
8-K
EX-10.1
2h8ovtb58y
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-10.1
n5xtn6
18 Feb 20
Adaptimmune Announces Appointment of Gavin Wood as Chief Financial Officer
8:07am
8-K
EX-10.1
gpswhab q8h
27 Jun 19
Departure of Directors or Certain Officers
8:08am
10-K
EX-10.18
mxe0 fwfwhi470
13 Mar 17
Annual report
12:00am
CORRESP
avezdqsq4jzybkm5lp
18 Oct 18
Correspondence with SEC
12:00am
10-K
EX-10.21
r7cv 0kwhbi
13 Mar 17
Annual report
12:00am
8-K
EX-10.2
ktvfz2 tzg4i
13 Jan 20
Adaptimmune Appoints Elliot Norry as Chief Medical Officer and Makes Changes to R&D Leadership
8:42am
8-K
EX-14.1
azawea38a q2rvgaw6
24 Jul 17
Amendments to the Registrant's Code of Ethics, or Waiver of a Provision of the Code of Ethics
12:00am